VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 25 filers reported holding VASCULAR BIOGENICS LTD in Q1 2017. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $229 | +6.0% | 937 | 0.0% | 0.00% | – |
| Q2 2023 | $216 | – | 937 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 937 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 937 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 937 | -6.3% | 0.00% | – |
| Q4 2021 | $2,000 | -33.3% | 1,000 | -44.6% | 0.00% | – |
| Q3 2018 | $3,000 | +200.0% | 1,805 | +257.4% | 0.00% | – |
| Q2 2018 | $1,000 | -66.7% | 505 | -55.5% | 0.00% | – |
| Q1 2018 | $3,000 | -72.7% | 1,134 | -36.3% | 0.00% | -100.0% |
| Q3 2017 | $11,000 | +22.2% | 1,781 | -15.8% | 0.00% | 0.0% |
| Q2 2017 | $9,000 | +800.0% | 2,114 | +957.0% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 200 | -17.4% | 0.00% | – |
| Q1 2016 | $1,000 | -66.7% | 242 | -48.9% | 0.00% | – |
| Q2 2015 | $3,000 | -94.6% | 474 | -95.6% | 0.00% | -100.0% |
| Q1 2015 | $56,000 | +600.0% | 10,836 | +665.8% | 0.01% | +600.0% |
| Q4 2014 | $8,000 | – | 1,415 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 2,593,286 | $5,751,000 | 0.66% |
| Ikarian Capital, LLC | 830,007 | $1,337,000 | 0.24% |
| Telemetry Investments, L.L.C. | 118,000 | $190,000 | 0.22% |
| Urban Wealth Management, LLC | 12,018 | $19,000 | 0.06% |
| DLD Asset Management, LP | 337,300 | $541,000 | 0.04% |
| Phoenix Holdings Ltd. | 513,597 | $827,000 | 0.02% |
| Caption Management, LLC | 140,000 | $225,000 | 0.00% |
| HBK Sorce Advisory LLC | 22,000 | $35,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 79,716 | $128,000 | 0.00% |
| Total Clarity Wealth Management, Inc. | 4,000 | $6,000 | 0.00% |